Vaccinated cancer patients may mount less robust humoral and/or cellular immune responses against SARS-CoV-2 compared with immunocompetent patients because of either the cancer treatment or the cancer itself, according to data shared at ASM Microbe 2023, held in Houston (poster 131).
Researchers enrolled 594 vaccinated people with different COVID-19 statuses: not known to have been infected, previously infected or living with long COVID. They assessed receptor-binding domain (RBD), total